About Us

Founded in 2021, Chemex Global is a manufacturer of APIs and Pharmaceutical Intermediates, located in Guwahati, Assam. We are a subsidiary of Jain Group Ventures, a company with over 30 years of experience in the Pharmaceutical Supply Chain Industry. We are committed to research-based indigenous solutions and have established one of the largest integrated R&D labs in Eastern India. We are proud to be the first API Manufacturing Unit in the Northeastern region of India and one of the biggest capacity units in the entire Eastern India.

APIs

APIs, or Active Pharmaceutical Ingredients, serve as the backbone of the pharmaceutical industry, and we pride ourselves on sourcing and providing top-notch APIs, ensuring the efficacy and safety of the medications we offer.

Our Products

Intermediates

Intermediates play a crucial role in the pharmaceutical industry, forming the essential building blocks in the production of drugs and medications. We specialise in providing a diverse range of comprehensive catalogue of these essential components,

Our Products

Why Choose Us?

Quality Assurance

Our stringent quality standards ensure the production of high-grade APIs and Pharma Intermediates, meeting global regulatory requirements with precision.

Research and Development Focus

We invest extensively in research and development, fostering a culture of innovation to introduce groundbreaking APIs and Pharma Intermediates.

Environmental Responsibility

 Employing cutting-edge technology and innovative processes, we manufacture APIs and Pharma Intermediates that adhere to the latest industry advancements.

State-of-the-art & GMP accredited

Our dedication to GMP regulations guarantees the production of high-quality APIs and Pharma Intermediates, meeting stringent global standards for quality control and environmental integrity.

Quality Assurance

Our stringent quality standards ensure the production of high-grade APIs and Pharma Intermediates, meeting global regulatory requirements with precision.

Research and Development Focus

We invest extensively in research and development, fostering a culture of innovation to introduce groundbreaking APIs and Pharma Intermediates.

Environmental Responsibility

 Employing cutting-edge technology and innovative processes, we manufacture APIs and Pharma Intermediates that adhere to the latest industry advancements.

State-of-the-art & GMP accredited

Our dedication to GMP regulations guarantees the production of high-quality APIs and Pharma Intermediates, meeting stringent global standards for quality control and environmental integrity.

View the Latest News

Plant Inauguration

On the 22nd of February, Chemex Global proudly inaugurated its cutting-edge pharma-API plant facility, marking a pivotal moment in our commitment to innovation, quality, and growth. This event served as a testament to our unwavering dedication to advancing the field of API and pharmaceutical intermediate production.

Introducing Our Recently Developed API- Sacubitril-Valsartan

As a newly developed API, Sacubitril Valsartan embodies our commitment to pushing the boundaries of pharmaceutical innovation. Manufactured to address the unmet needs of patients suffering from chronic heart failure
Scroll to Top

Plant Inauguration

On the 22nd of February, Chemex Global proudly inaugurated its cutting-edge pharma-API plant facility, marking a pivotal moment in our commitment to innovation, quality, and growth. This event served as a testament to our unwavering dedication to advancing the field of API and pharmaceutical intermediate production. The inauguration ceremony was a momentous occasion, graced by esteemed guests who shared our vision for the future of pharmaceutical manufacturing. With our state-of-the-art plant now operational, we are poised to meet the evolving needs of our customers and partners, delivering high-quality APIs and pharmaceutical intermediates that make a difference in people’s lives. As we embark on this new chapter in our journey, we are excited about the opportunities that lie ahead. Our newly inaugurated plant represents not only a physical structure but also a symbol of our commitment to pushing the boundaries of pharmaceutical manufacturing and setting new standards of excellence.

Introducing Our Recently Developed API- Sacubitril-Valsartan

As a newly developed API, Sacubitril Valsartan embodies our commitment to pushing the boundaries of pharmaceutical innovation. Manufactured to address the unmet needs of patients suffering from chronic heart failure, this breakthrough API offers new hope and improved outcomes. Our team of dedicated scientists and researchers has spared no effort in bringing Sacubitril Valsartan to fruition. From the initial concept to the final formulation, every aspect of its development has been carefully orchestrated to meet and exceed the stringent standards set forth by regulatory authorities,ensuring efficacy, safety, and quality. With Sacubitril Valsartan, we aim to revolutionise cardiovascular care and make a meaningful difference in the lives of patients worldwide.
Ready to catalyse your next breakthrough in the pharmaceutical industry? We’d be happy to help you.

Got any queries?